<PAGE>
                                                                   Exhibit 10(e)

                      DANNINGER MEDICAL TECHNOLOGY, INC.

                                 
                             EMPLOYMENT AGREEMENT
                             --------------------


     THIS EMPLOYMENT AGREEMENT is made this 7th day of November, 1996,
("Agreement") between Danninger Medical Technology, Inc., a Delaware corporation
("Danninger"), and Philip A. Mellinger ("Executive").


                             Recitals

     A.   Danninger is the owner, directly or indirectly, of all of the issued
capital stock of Cross Medical Products, Inc., an Ohio corporation, and
Danninger Healthcare, Inc., an Ohio corporation (individually a "Subsidiary" and
collectively the "Subsidiaries").

     B.   Danninger and its Subsidiaries (collectively, the "Company") design,
manufacture, sell and lease medical and surgical equipment, devices and
instruments.

     C.   The Executive is currently employed as an executive of Danninger or
one of its Subsidiaries.

     D.   The Company considers the continued services of the Executive to be in
the best interest of the Company and desires to assure the continued services of
the Executive on behalf of the Company on an objective and impartial basis and
without distraction or conflict of interest in the event of an attempt to obtain
control of the Company.

     E.   The Executive is willing to remain in the employ of the Company upon
the understanding that the Company will provide income security in the event of
a change in control of the Company.

     F.   Danninger and the Executive desire to enter into an employment
relationship upon the terms and conditions contained herein.

     NOW, THEREFORE, the parties agree as follows:

     1.   EMPLOYMENT.  Danninger hereby employs the Executive and the Executive
accepts such employment upon the terms and conditions hereinafter set forth.

     2.   DUTIES.  The Executive shall be employed:

          (a)  to serve as Director of Research and Development of Cross Medical
     Products, Inc., and to serve in other capacities for each of Danninger and
     the Subsidiaries,


<PAGE>

     if so elected, subject to the authority and direction of the Board of 
     Directors of Danninger or such Subsidiary, as the case may be; and

          (b)  to perform such other duties and responsibilities similar to
     those performed by the Executive prior hereto and exercise such other
     authority, perform such other or additional duties and responsibilities and
     have such other or different title (or have no title) as the Board of
     Directors of Danninger may, from time to time, prescribe.

     So long as he is employed under this Agreement, the Executive agrees to
devote his full time and efforts exclusively on behalf of the Company and to
competently, diligently, and effectively discharge his duties hereunder.  The
Executive shall not be prohibited from engaging in such personal, charitable, or
other nonemployment activities as do not interfere with his full time employment
hereunder and which do not violate the other provisions of this Agreement.  The
Executive further agrees to comply fully with all reasonable policies of the
Company as are from time to time in effect.

     3.   COMPENSATION.  As his entire compensation for all services rendered to
the Company pursuant to this Agreement, in whatever capacity rendered, the
Company shall pay to the Executive during the term hereof a minimum base salary
at the rate of $80,000.00 per year ("Basic Salary"), payable monthly or in other
more frequent installments, as determined by the Company.  The Basic Salary may
be increased, but not decreased, from time to time, by the Board of Directors.

     In addition, the Executive will be entitled to receive incentive
compensation pursuant to the terms of plans adopted by the Board of Directors
from time to time.

     4.   BUSINESS EXPENSES.  The Company shall promptly pay directly, or
reimburse the Executive for, all business expenses to the extent such expenses
are paid or incurred by the Executive during the term of employment in
accordance with Company policy in effect from time to time and to the extent
such expenses are reasonable and necessary to the conduct by the Executive of
the Company's business and properly substantiated.

     5.   FRINGE BENEFITS.  During the term of this Agreement and the
Executive's employment hereunder, the Company shall provide to the Executive
such insurance, vacation, sick leave and other like benefits as are provided
from time to time to its other employees holding equivalent executive positions
with the Company in accordance with the policy of the Company as may be
established from time to time; provided, however, that the Company shall
maintain at least the level of benefits presently provided to the Executive.

     6.   TERM; TERMINATION.  The Executive is employed by the Company "at
will." The Executive's employment may be terminated at any time as provided
below.  For purposes of this Section 6, "Termination Date" shall mean the date
on which any notice period required under


                                       2
<PAGE>

this Section 6 expires or, if no notice period is specified in this Section 6, 
the effective date of the termination referenced in the notice.
 
          (a)  TERMINATION BY THE EXECUTIVE.  The Executive may terminate his
     employment upon giving at least 30 days' advance written notice to the
     Company and the Company will pay the Executive the earned but unpaid
     portion of the Executive's Basic Salary through the Termination Date.  If
     the Executive gives notice of termination hereunder, the Company shall have
     the right to relieve the Executive, in whole or in part, of his duties
     under this Agreement and to advance the Termination Date from the date set
     by the Executive's notice to a date not less than 14 days from the receipt
     of the Executive's notice of termination.

          (b)  TERMINATION BY COMPANY WITHOUT CAUSE.  The Company may terminate
     the Executive's employment without cause upon giving 30 days' advance
     written notice to the Executive.  If the Executive's employment is
     terminated without cause under this Section 6(b), the Company will pay the
     Executive the earned but unpaid portion of the Executive's Basic Salary
     through the Termination Date and will continue to pay the Executive his
     Basic Salary for 6 months following the Termination Date ("Severance
     Period"); provided, however, that the Company may terminate payment of the
     Basic Salary during the Severance Period if the Executive accepts other
     employment or is in breach of obligations under Sections 7 or 8 of this
     Agreement.
          
          (c)  TERMINATION BY COMPANY FOR GOOD CAUSE.  The Company may terminate
     the Executive's employment  upon a determination by the Company that "Good
     Cause" exists for the Executive's termination and the Company serves
     written notice of such termination upon the Executive.  As used in this
     Agreement, the term "Good Cause" shall refer only to any one or more of the
     following actions by the Executive:

               (i) commission of an act of dishonesty, including, but not
          limited to, misappropriation of funds or any property of the Company;

               (ii) engagement in activities or conduct clearly injurious to the
          reputation of the Company;

               (iii) refusal to perform his assigned duties and
          responsibilities;

               (iv) gross insubordination;

               (v) the clear violation of any of the material terms and
          conditions of this Agreement or any written agreement or agreements
          the Executive may from time to time have with the Company (following
          30-days' written notice from the Company specifying the violation and
          the Executive's failure to cure such violation within such 30-day
          period); or


                                       3
<PAGE>

               (vi) commission of a misdemeanor involving an act of moral
          turpitude or a felony.

In the event of a termination under this Section 6(c), the Company will pay the
Executive the earned but unpaid portion of the Executive's Basic Salary through
the Termination Date.

          (d)  TERMINATION UPON DEATH OR PERMANENT DISABILITY.  The Executive's
     employment shall terminate upon the death or permanent disability of the
     Executive.  For purposes hereof, "permanent disability," shall mean the
     inability of the Executive, as determined by the Board of Directors of the
     Company, by reason of physical or mental illness to perform the duties
     required of him under this Agreement for more than 180 days in any one year
     period.  Successive periods of disability, illness or incapacity will be
     considered separate periods unless the later period of disability, illness
     or incapacity is due to the same or related cause and commences less than
     six months from the ending of the previous period of disability.  Upon a
     determination by the Board of Directors of Danninger that the Executive's
     employment shall be terminated under this Section 6(d), the Board of
     Directors shall give the Executive 30 days' prior written notice of the
     termination.  If a determination of the Board of Directors under this
     Section 6(d) is disputed by the Executive, the parties agree to abide by
     the decision of a panel of three physicians.  The Company will select a
     physician, the Executive will select a physician and the physicians
     selected by the Company and the Executive will select a third physician. 
     The Executive agrees to make himself available for and submit to
     examinations by such physicians as may be directed by the Company.  Failure
     to submit to any examination shall constitute a breach of a material part
     of this Agreement.  In the event of a termination under this Section 6(d),
     the Company will pay Executive or his duly appointed and qualified executor
     or other personal representative the earned but unpaid portion of the
     Executive's Basic Salary through the Termination Date.

          (e)  TERMINATION FOLLOWING CHANGE OF CONTROL.    If a "Change in
     Control", as defined in Section 6(e)(v), shall have occurred and within one
     year following such Change in Control the Company terminates the employment
     of the Executive for other than Good Cause, as defined in Section 6(c), or
     the Executive terminates his employment for Good Reason, as that term is
     defined in Section 6(e)(vii), then the Executive shall be entitled to the
     benefits described below:

               (i)  The Executive shall be entitled to the unpaid portion of his
          Basic Salary plus credit for any vacation accrued but not taken and
          the amount of any unpaid but earned bonus, incentive compensation or
          any other benefit to which he is entitled under this Agreement through
          the date of the termination as a result of a Change in Control, plus 2
          times the Executive's "Current Annual Compensation" as defined in this
          Section 6(e)(i) ("Salary Termination Benefit").  For this purpose
          "Current Annual Compensation" shall mean the total of Executive's
          Basic Salary in effect at the Termination Date, plus any performance
          bonuses received by Executive in


                                       4
<PAGE>

          the prior twelve months, and shall not include the value of any stock 
          options granted or exercised, contributions to 401(k) or other 
          qualified plans, medical, dental, or other insurance benefits, or 
          other fringe benefits.  The Salary Termination Benefit shall be paid 
          to the Executive in 24 equal consecutive monthly payments commencing 
          on the first day of the month after termination of employment 
          following a Change in Control.
     
               (ii)  All outstanding stock options issued to the Executive shall
          become 100% vested and thereafter exercisable in accordance with such
          governing stock option agreements and plans.
     
               (iii)  The Company shall maintain for the Executive's benefit
          until the earlier of (y) 24 months after termination of employment
          following a Change in Control, or (z) the Executive's commencement of
          full-time employment with a new employer, all life insurance, medical,
          health and accident, and disability plans or programs in which the
          Executive shall have been entitled to participate prior to termination
          of employment following a Change in Control, provided the Executive's
          continued participation is permitted under the general terms of such
          plans and programs after the Change in Control ("Fringe Termination
          Benefits";  collectively the Salary Termination Benefit and the Fringe
          Termination Benefit are referred to as the "Termination Benefits"). 
          In the event the Executive's participation in any such plan or program
          is not permitted, the Company will provide directly the benefits to
          which the Executive would be entitled under such plans and programs.
     
               (iv)  The Termination Benefits shall be payable to the Executive
          as severance pay in consideration of his past service and of his
          continued services from the date hereof.  Executive shall have no duty
          to mitigate his damages by seeking other employment, and the Company
          shall not be entitled to set off against amounts payable hereunder any
          compensation which the Executive may receive from future employment.

               (v)  A "Change in Control" shall be deemed to have occurred if
          and when, after the date hereof, (i) Danninger, or in one or more
          transactions 50% or more of its assets or earning power, is acquired
          by or combined with a person, partnership, corporation, trust or other
          entity ("Person") and less than a majority of the outstanding voting
          shares of the Person surviving such transaction (or the ultimate
          parent of the surviving Person) after such acquisition or combination
          is owned, immediately after the acquisition or combination, by the
          owners of the voting shares of the Company outstanding immediately
          prior to such acquisition or combination; or (ii) during any period of
          two consecutive years during the term of this Agreement, individuals
          who at the beginning of such period constitute the Board of Directors
          of Danninger cease for any reason to constitute at least two-


                                       5
<PAGE>

          thirds thereof, unless the election of each director who was not a 
          director at the beginning of such period has been approved in advance 
          by directors representing at least two-thirds of the directors then in
          office who were directors at the beginning of the period.

               (vi)  If the payments and benefits provided under this Agreement
          to the Executive, either alone or with other payments and benefits,
          would constitute "excess parachute payments" as defined in 
          Section 280G of the Internal Revenue Code of 1986, as amended 
          ("Code"), then the payments and other benefits under this Agreement 
          shall be reduced to the extent necessary so that no portion thereof 
          shall be subject to the excise tax imposed by Section 4999 of the 
          Code.  Either the Company or the Executive may request a determination
          as to whether the payments or benefits would constitute an excess 
          parachute payment and, if requested, such determination shall be made 
          by independent tax counsel selected by the Company and approved by the
          Executive.  At the Executive's election and to the extent not 
          otherwise paid, the Executive may determine the amount of cash and/or 
          elements of non-cash fringe benefits to reduce so that such payments 
          and benefits will not constitute excess parachute payments.


               (vii)   As used in this Agreement, the term "Good Reason" means,
          without the Executive's written consent, 

                    (a) a change in status, position or responsibilities which,
               in the Executive's reasonable judgment, does not represent a
               promotion from existing status, position or responsibilities as
               in effect immediately prior to the Change in Control; the
               assignment of any duties or responsibilities which, in the
               Executive's reasonable judgment, are inconsistent with such
               status, position or responsibilities; or any removal from or
               failure to reappoint or reelect the Executive to any of such
               positions, except in connection with the termination for total
               and permanent disability, death or Good Cause or by him other
               than for Good Reason; 

                    (b) a reduction by the Company in the Executive's base
               salary as in effect on the date hereof or as the same may be
               increased from time to time during the term of this Agreement or
               the Company's failure to increase (within twelve months of the
               Executive's last increase in base salary) the Executive's base
               salary after a Change in Control in an amount which at least
               equals, on a percentage basis, the average percentage increase in
               base salary for all executive and senior officers of the Company
               effected in the preceding twelve months; 


                                       6
<PAGE>

                    (c) the relocation of the Company's principal executive
               offices to a location outside the Columbus metropolitan area or
               the relocation of the Executive by the Company to any place other
               than the location at which the Executive performed duties prior
               to a Change in Control, except for required travel on the
               Company's business to an extent substantially consistent with
               business travel obligations at the time of a Change in Control; 

                    (d) the failure of the Company to continue in effect any
               incentive, bonus or other compensation plan in which the
               Executive participates, including but not limited to the
               Company's stock option plans, unless an equitable arrangement
               (embodied in an ongoing substitute or alternative plan),
               evidenced by the Executive's written consent, has been made with
               respect to such plan in connection with the Change in Control, or
               the failure by the Company to continue the Executive's
               participation therein, or any action by the Company which would
               directly or indirectly materially reduce participation therein; 

                    (e) the failure by the Company to continue to provide the
               Executive with benefits substantially similar to those enjoyed or
               entitled under any of the Company's pension, profit sharing, life
               insurance, medical, dental, health and accident, or disability
               plans at the time of a Change in Control, the taking of any
               action by the Company which would directly or indirectly
               materially reduce any of such benefits or deprive the Executive
               of any material fringe benefit enjoyed or entitled to at the time
               of the Change in Control, or the failure by the Company to
               provide the number of paid vacation and sick leave days to which
               the Executive is entitled on the basis of years of service with
               the Company in accordance with the Company's normal vacation
               policy in effect on the date hereof; 

                    (f) the failure of the Company to obtain a satisfactory
               agreement from any successor or assign of the Company to assume
               and agree to perform this Agreement or; 

                    (g) any request by the Company that the Executive
               participate in an unlawful act or take any action constituting a
               breach of the Executive's professional standard of conduct. 
               Notwithstanding anything in this Section to the contrary, the
               Executive's right to terminate the employment pursuant to this
               Section shall not be affected by incapacity due to physical or
               mental illness.

               (viii)  Upon any termination or expiration of this Agreement or
          any cessation of the Executive's employment hereunder, the Company
          shall have no further obligations under this Agreement and no further
          payments shall be payable


                                       7
<PAGE>

          by the Company to the Executive, except as provided in Sections 6(b) 
          and 6(e) above and except as required under any benefit plans or 
          arrangements maintained by the Company and applicable to the Executive
          at the time of such termination, expiration or cessation of the 
          Executive's employment, including, without limitation thereto, salary,
          incentive compensation, sick leave, and vacation pay.

               (ix)   ENFORCEMENT OF AGREEMENT.  The Company is aware that upon
          the occurrence of a Change in Control, the Board of Directors or a
          shareholder of the Company may then cause or attempt to cause the
          Company to refuse to comply with its obligations under this Agreement,
          or may cause or attempt to cause the Company to institute, or may
          institute litigation seeking to have this Agreement declared
          unenforceable, or may institute litigation seeking to have this
          Agreement declared unenforceable, or may take or attempt to take other
          action to deny the Executive the benefits intended under this
          Agreement.  In these circumstances, the purpose of this Agreement
          could be frustrated.  It is the intent of the Company that the
          Executive not be required to incur the expenses associated with the
          enforcement of any rights under this Agreement by litigation or other
          legal action, nor be bound to negotiate any settlement of any rights
          hereunder, because the cost and expense of such legal action or
          settlement would substantially detract from the benefits intended to
          be extended to the Executive hereunder.  Accordingly, if following a
          Change in Control it should appear to the Executive that the Company
          has failed to comply with any of its obligations under this Agreement
          or in the event that the Company or any other person takes any action
          to declare this Agreement void or enforceable, or institutes any
          litigation or other legal action designed to deny, diminish or to
          recovery from the Executive the benefits entitled to be provided to
          the Executive hereunder, and that the Executive has complied with all
          obligations under this Agreement, the Company irrevocably authorizes
          the Executive from time to time to retain counsel of the Executive's
          choice, at the expense of the Company as provided in this Section, to
          represent the Executive in connection with the initiation or defense
          of any litigation or other legal action, whether such action is by or
          against the Company or any Director, officer, shareholder, or other
          person affiliated with the Company, in any jurisdiction. 
          Notwithstanding any existing or prior attorney-client relationship
          between the Company and such counsel, the Company irrevocably consents
          to the Executive entering into an attorney-client relationship with
          such counsel, and in that connection the Company and the Executive
          agree that a confidential relationship shall exist between the
          executive and such counsel.  The reasonable fees and expenses of
          counsel selected from time to time by the Executive as hereinabove
          provided shall be paid or reimbursed to the Executive by the Company
          on a regular, periodic basis upon presentation by the Executive of a
          statement or statements prepared by such counsel in accordance with
          its customary practices, up to a maximum aggregate amount of $200,000.
          Any legal expenses incurred by the Company by reason of any dispute
          between the parties as to enforceability of or the terms contained in
          this Agreement, notwithstanding the outcome of any such dispute,


                                       8
<PAGE>

          shall be the sole responsibility of the Company, and the Company 
          shall not take any action to seek reimbursement from the Executive 
          for such expenses.

     7.   NON-COMPETITION.  

          (a) The Executive agrees that he will not during the term of this
     Agreement, any extension hereof, and for a period of 12 months after
     termination of employment with the Company, whether voluntary or
     involuntary or with or without cause:

               (i)  engage or participate, directly or indirectly, either as
          principal, agent, employee, employer, consultant, stockholder (except
          as the holder of not more than two percent of the stock of any
          publicly traded corporation), or in any other individual or
          representative capacity whatsoever, in the operation, management or
          ownership of any business, firm, corporation, association, or other
          entity engaged in the design, manufacture, marketing, sale or lease of
          continuous passive motion, thermal therapy or similar orthopedic
          rehabilitation devices, spinal implants, or spinal instruments, or any
          other business engaged in by the Company at any time during the term
          of this Agreement, or during the 12 month period after termination;
          and,

               (ii)  directly or indirectly, for himself or in conjunction with
          or on behalf of any other individual or entity, solicit, divert, take
          away or endeavor to take away from the Company any customer, account
          or employee of the Company at any time during the term of this
          Agreement, as of the date of the Executive's termination of employment
          with the Company, or during the 12 month period after termination.
 
          (b)  In the event of a violation of this Section 7, the 
     non-competition time period provided in Section 7(a) shall be tolled during
     the time of such violation.

     8.   CONFIDENTIAL INFORMATION; ASSIGNMENT OF INVENTIONS.

          (a)  As used herein, the term "Confidential Information" includes, but
     is not limited to, all information and materials belonging to, used by, or
     in the possession of the Company (i) which have been disclosed or made
     known to, or has come into the possession of the Executive as a consequence
     of or through the Executive's relationship with the Company prior to or
     after the date hereof, (ii) which are related to the Company's  customers,
     potential customers, suppliers, distributors, business strategies or
     policies, financial or sales results, sales and management techniques,
     marketing plans, research or development, reports, records, software,
     systems, source or object code, software documentation or instruction or
     user manuals, and (iii) which have not generally been made available to the
     public (not including customers) by the Company pursuant to a specific
     authorization in the ordinary course of business by the Company of the
     release of


                                       9
<PAGE>

     such information to the public or otherwise published and released by the 
     Company to the general public.  Notwithstanding the foregoing, the 
     Executive may release Confidential Information if (1) required by law, 
     (2) necessary to establish a lawful claim or defense against the Company, 
     (3) necessary to establish a lawful claim or defense against a person or 
     entity other than the Company, but only with the permission, which shall 
     not be unreasonably withheld, of the Company, or (4) necessary to respond 
     to process or appropriate governmental inquiry, but then in each case only 
     with prior notice to the Company.

          (b)  The Executive agrees:

               (i)  that the Executive will promptly disclose and grant and does
          hereby grant to the Company his entire right, title and interest in
          and to all customer lists, discoveries, developments, designs,
          improvements, inventions, formulae, software, documentation,
          processes, techniques, know-how, patents, trade secrets and
          trademarks, copyrights and all other data conceived, developed or
          acquired by him during the period of his employment with the Company,
          both prior to and after the execution of this Agreement, whether or
          not patentable or registrable under copyright or similar statutes,
          made or conceived or reduced to practice or learned by the Executive,
          either alone or jointly with others, that result from or are conceived
          during the performance of tasks assigned to the Executive by the
          Company or result from use of property, equipment, or premises owned,
          leased or contracted for by the Company ("Inventions").  The Executive
          agrees to execute and deliver, from time to time, such documents as
          may be necessary or convenient to effectuate the transfer of such
          Confidential Information to the Company and shall cooperate with and
          assist the Company in every proper way (at the expense of the Company)
          in obtaining and from time to time enforcing patents, copyrights,
          trade secrets, other proprietary rights and protections relating to
          Inventions in any and all countries;

               (ii) that the Executive will during the term of this Agreement
          and thereafter safeguard all Confidential Information and, except as
          specifically permitted in Section 8(b)(iii) and Section 8(b)(iv), the
          Executive will never disclose or use for any purpose or benefit (other
          than for the purpose or benefit of the Company) any Confidential
          Information;

               (iii) that, except in connection with the ordinary course of the
          Company's business, the Executive will not, either during the term of
          this Agreement or thereafter directly or indirectly, disclose,
          disseminate or otherwise make known or provide any Confidential
          Information, whether in original form or in duplicated or copied form
          or extracts therefrom, and whether orally or in writing, to any
          individual, partnership, company or other entity, unless the Company
          has given its prior written consent thereto;


                                      10
<PAGE>

               (iv) that, except in connection with the ordinary course of the
          Company's business, the Executive will not, either during the term of
          this Agreement or thereafter, remove any Confidential Information from
          the premises of the Company either in original form or in duplicated
          or copied form or extracts therefrom; and that upon any termination of
          Executive's employment by the Company, Executive will immediately
          surrender to the Company, without request, all Confidential
          Information, whether in original or duplicated or copied form or
          extracts therefrom.

     9.   NO CONFLICTS.  The Executive represents that the performance by the
Executive of all the terms of this Agreement, as a former or continuing employee
of the Company  does not and will not breach any agreement as to which the
Executive or the Company is or was a party and which requires Executive to keep
any information in confidence or in trust.  The Executive has not entered into,
and will not enter into, any agreement either written or oral in conflict
herewith.  

     10.  REASONABLENESS OF RESTRICTIONS.  The Executive acknowledges that the
restrictions contained in this Agreement are reasonable but should any
provisions of this Agreement be determined to be invalid, illegal or otherwise
unenforceable to its full extent, or if any such restriction is found by a court
of competent jurisdiction to be unreasonable under applicable law, then the
restriction shall be enforced to the maximum extent permitted by law, and the
parties hereto hereby consent and agree that such scope of protection, time or
geographic area (or any one of them, as the case may be) shall be modified
accordingly in any proceeding brought to enforce such restriction.  The
Executive acknowledges that the validity, legality and enforceability of the
other provisions shall not be affected thereby.  The Executive hereby
acknowledges and confirms that the business of the Company extends at least
throughout the world and that, without limitation of any  remedies for breach of
such covenant, the Company shall be entitled to temporary and permanent
injunctive relief.

     11.  REMEDIES; VENUE; PROCESS.  

          (a) The Executive hereby acknowledges and agrees that the Confidential
     Information disclosed to the Executive prior to and during the term of this
     Agreement is of a special, unique and extraordinary character, and that any
     breach of this Agreement will cause the Company irreparable injury and
     damage, and consequently the Company  shall be entitled, in addition to all
     other remedies available to it, to injunctive and equitable relief to
     prevent or cease a breach of Sections 7 or 8 of this Agreement without
     further proof of harm and entitlement; that the terms of this Agreement, if
     enforced by the Company, will not unduly impair the Executive's ability to
     earn a living or pursue his vocation; and further, that the Company may
     withhold compensation and benefits if the Executive fails to comply with
     this Agreement, without restricting the Company from other legal and
     equitable remedies.  The parties agree that the prevailing party shall be
     entitled to all costs and expenses (including reasonable legal fees and
     expenses) which it


                                      11
<PAGE>

     incurs in successfully enforcing this Agreement and in prosecuting or 
     defending any litigation (including appellate proceedings) arising out of 
     this Agreement.

          (b)  The parties agree that jurisdiction and venue in any action
     brought pursuant to this Agreement to enforce its terms or otherwise with
     respect to the relationships between the parties shall properly lie in the
     Court of Common Pleas of Franklin County, Ohio.  Such jurisdiction and
     venue is exclusive, except that the Company may bring suit in any
     jurisdiction and venue where jurisdiction and venue would otherwise be
     proper if Executive has breached Sections 7 or 8 of this Agreement.  The
     parties further agree that the mailing by certified or registered mail,
     return receipt requested, of any process required by any such court shall
     constitute valid and lawful service of process against them, without the
     necessity for service by any other means provided by statute or rule of
     court.
     
     12.  WITHHOLDING.  The Company may withhold from any payments to be made
hereunder such amounts as it may be required to withhold under applicable
federal, state or other law, and transmit such withheld amounts to the
appropriate taxing authority.

     13.  ASSIGNMENT.  This Agreement is personal to the Executive and the
Executive may not assign or delegate any of his rights or obligations hereunder.
Subject to the foregoing, this Agreement shall be binding upon and inure to the
benefit of the respective parties hereto, their heirs, executors,
administrators, successors and assigns.

     14.  WAIVER.  The waiver by either party hereto of any breach or violation
of any provision of this Agreement by the other party shall not operate as or be
construed to be a waiver of any subsequent breach by such waiving party.

     15.  NOTICES.  Any and all notices required or permitted to be given under
this Agreement will be sufficient and deemed effective three (3) days following
deposit in the United States mail if furnished in writing and sent by certified
mail to the Executive at:

          Philip A. Mellinger
          1094 Kirk Avenue
          Worthington, OH  43085

and to the Company at:  

          Danninger Medical Technology, Inc.
          5160-B Blazer Memorial Parkway
          Dublin, OH 43017-1339
          Attention:  President


                                      12
<PAGE>

with a copy to:     

          Curtis A. Loveland, Esq.
          Porter, Wright, Morris & Arthur
          41 South High Street
          Columbus, Ohio 43215


     16.  GOVERNING LAW.  This Agreement shall be interpreted, construed and
governed according to the laws of the State of Ohio applicable to contracts made
and to be wholly performed within such state.

     17.  AMENDMENT.  This Agreement may be amended in any and every respect by
agreement in writing executed by both parties hereto.

     18.  SECTION HEADINGS.  Section headings contained in this Agreement are
for convenience only and shall not be considered in construing any provision
hereof.

     19.  ENTIRE AGREEMENT.  This Agreement terminates, cancels and supersedes
all previous employment agreements or other agreements relating to the
employment of the Executive with the Company, written or oral, entered into
between the parties hereto, and this Agreement contains the entire understanding
of the parties hereto with respect to the subject matter of this Agreement. 
This Agreement was fully reviewed and negotiated on behalf of each party and
shall not be construed against the interest of either party as the drafter of
this Agreement.    THE EXECUTIVE ACKNOWLEDGES THAT, BEFORE PLACING HIS SIGNATURE
HEREUNDER, HE HAS READ ALL OF THE PROVISIONS OF THIS EMPLOYMENT AGREEMENT AND
HAS THIS DAY RECEIVED A COPY HEREOF.

     20.  SEVERABILITY.  The invalidity or unenforceability of any one or more
provisions of this Agreement shall not affect the validity or enforceability of
any other provisions of this Agreement or parts thereof.

     21.  SURVIVAL.  Sections 6 through 13 of this Agreement and this Section 21
shall survive any termination or expiration of this Agreement.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the day and year first above written.


EXECUTIVE:                             DANNINGER MEDICAL TECHNOLOGY, INC.


/s/ Philip A. Mellinger                    By: /s/ Joseph A. Mussey
----------------------------------         ------------------------------------
Philip A. Mellinger                        Joseph A. Mussey, President


                                      13